GlassScriptPhysician profile
Olatunde Osofisan
NPI 1306129341
$112,307.06
in general payments reported to CMS, 2019-2025
42 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $17K · 2021: $21K · 2022: $12K · 2023: $7,412 · 2024: $6,215 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Royalty Or License: $6,694 · Travel and Lodging: $6,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,907.27 |
| Royalty Or License | $6,693.81 |
| Travel and Lodging | $6,578.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $53,091.57 | 2019-2022 | |
| Stryker Corporation | $18,058.42 | 2019-2025 | Prostep, Citrefix, Augment Injectable |
| Novastep INC. | $11,285.60 | 2021-2025 | Arcad |
| Cardiovascular Systems INC. | $4,849.67 | 2019-2023 | Diamondback Peripheral |
| Treace Medical Concepts, INC. | $3,602.26 | 2023-2025 | |
| Abbott Laboratories | $3,174.23 | 2021-2025 | Gallant, Aveir, Diamondback Peripheral |
| Trilliant Surgical LLC. | $2,799.01 | 2019-2022 | |
| Acumed LLC | $2,255.12 | 2022-2025 | Acumed, Osteomed, Acumed |
| Linvatec Corporation | $1,673.17 | 2022-2025 | Biobrace 23mm, Colink Plating System, Fracture and Correction Colag 2 |
| Smith+Nephew, INC. | $1,263.26 | 2019-2022 | |
| Mimedx Group, INC. | $1,214.80 | 2024 | |
| Wright Medical Technology, INC. | $833.98 | 2019-2020 | |
| Vilex LLC | $800.00 | 2020 | |
| In2bones USA, LLC | $800.00 | 2021 | |
| Aroa Biosurgery Incorporated | $789.91 | 2024-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $759.01 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Polynovo North America LLC | $657.43 | 2024-2025 | Novosorb Btm |
| Nevro Corp. | $605.66 | 2022-2024 | Senza |
| Integra Lifesciences Corporation | $531.61 | 2019-2020 | |
| Organogenesis INC. | $450.26 | 2019-2025 | Cygnus Dual, Puraply Wound Matrix, Apligraf |
| Paratek Pharmaceuticals, INC. | $399.60 | 2022-2024 | Nuzyra |
| Medtronic, INC. | $257.39 | 2024-2025 | Closurefast |
| Djo, LLC | $243.25 | 2025 | Cmf |
| Abbvie INC. | $199.99 | 2021 | |
| Acera Surgical, INC. | $194.07 | 2022 | |
| Encore Medical, LP | $178.63 | 2022 | |
| Osiris Therapeutics INC. | $164.77 | 2019 | |
| Osteomed LLC | $164.16 | 2021 | |
| Globus Medical, INC. | $157.58 | 2025 | Senza |
| Kerecis Limited | $154.89 | 2022 | |
| Medshape, INC. | $153.83 | 2022 | |
| Pfizer INC. | $120.20 | 2019 | |
| Orthofix Medical, INC. | $76.83 | 2024 | Physio-Stim |
| Lifenet Health | $67.69 | 2025 | Theragenesis Wound Matrix |
| Paragon 28, INC. | $66.17 | 2020 | |
| Averitas Pharma INC. | $51.48 | 2024-2025 | Qutenza |
| Kci USA, INC. | $43.41 | 2021 | |
| Horizon Therapeutics Plc | $36.03 | 2021 | |
| Glaxosmithkline, LLC. | $24.50 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $22.60 | 2024 | |
| Solventum Corporation | $20.52 | 2025 | Activ.A.C. |
| Sanofi Pasteur INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olatunde Osofisan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.